The FDA will warn about overuse or misuse of semaglutide (Ozempic, Wegovy and Rybelsus) before the end of 2024.
29
1kṀ5413resolved Jan 25
Resolved
NO1D
1W
1M
ALL
This question is managed and resolved by Manifold.
Get
1,000 to start trading!
🏅 Top traders
# | Name | Total profit |
---|---|---|
1 | Ṁ304 | |
2 | Ṁ148 | |
3 | Ṁ81 | |
4 | Ṁ31 | |
5 | Ṁ28 |
Sort by:
We had a 3 mod panel with @CodeandSolder and @Ziddletwix on Discord.
There was a unanimous agreement to resolve no. We considered the warnings against compounded Semaglutide being potentially dangerous, but did not feel they met the criteria established in this market about overuse or misuse. They were more a general warning to be careful with these products in specific forms.
I'm not sure if that should count or not: https://www.fda.gov/drugs/human-drug-compounding/fda-alerts-health-care-providers-compounders-and-patients-dosing-errors-associated-compounded
@CodeandSolder this feels like a judgement call situation to me. We probably need to do the 3 mod panel thing. Unless there are more warnings out there.
Related questions
Related questions
Will semaglutide be taken off FDA's drug shortage list in 2025?
65% chance
FDA issues statement/update on Ozempic NAION risk by March 31, 2025
24% chance
Will one of the GLP agonist drugs (eg Semaglutude/Wegovy Tirzepatide/Mounjaro) have a black box warning by 2025
7% chance
Will Ozempic / semaglutide be FDA-approved for Alzheimer's before 2030?
58% chance
Will Matt Kaeberlein start taking semaglutide/ozempic by 2030?
41% chance
Will there be a recall of Wegovy/Ozempic before 2035?
80% chance
How many OECD countries will have court ordered semaglutide drugs (e.g., Ozempic) by the end of 2030
Will 10 million Americans be on semaglutide (or yet-to-be-approved equally good or superior alternatives) by the end of 2030?
78% chance
Ozempic will NOT be the leading GLP-1 agonist by total $ US sales by December 31, 2025
42% chance
Will the Ozempic shortage be resolved on December 31st, 2025 according to the FDA?
58% chance